Adagene and Exelixis Expand SAFEbody Collaboration to Develop Third Masked Antibody-Drug Conjugate Read more
FDA Grants Breakthrough Therapy Designation to Raludotatug Deruxtecan for CDH6-Positive Platinum-Resistant Ovarian and Related Cancers Read more
Cadrenal Boosts Anticoagulation Pipeline with Acquisition of eXIthera’s Factor XIa Inhibitors Read more